A randomised controlled pilot trial investigating the feasibility of monitoring patients with or at risk for cardiovascular disease who have symptoms suspected of COVID-19 by pulse oximetry at home
Recruiting
- Conditions
- Patients presenting to primary care with moderate to severe symptoms of COVID-19 (both SARS-CoV-2 positive and untested patients).
- Registration Number
- NL-OMON25226
- Lead Sponsor
- MC Utrecht
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Not specified
- Target Recruitment
- 50
Inclusion Criteria
1) Age =40 years
2) Cardiovasculair risk profile or cardiovascular disease (overweight, hypertension, diabetes, smoking, coronary artery disease, previous myocardial infarction, heart failure)
3) Presumably COVID-19 (both SARS-CoV-2 positive and non-COVID-19 confirmed patients)
4) Moderate-severe symptoms
5) Mentally competent
Exclusion Criteria
1) Severe illness requiring hospital admission
2) Patient does not want future hospitalisation
3) Known anemia
4) Inadequate mastery of the Dutch language
5) Not willing to sign informed consent
6) Not willing to adhere to study procedures
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Feasibility defined as successful inclusion of 50 participants within 6 months
- Secondary Outcome Measures
Name Time Method